+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Immunoglobulin therapy in immunohematological disorders



Immunoglobulin therapy in immunohematological disorders



Indian Journal of Pediatrics 65(5): 681-690



Over the last few decades many biological factors have been discovered. Among these immunoglobulins are currently being used for large number of indications. Initially it was used for primary and secondary immunodeficiency states. Subsequently, intravenous immunoglobulins are being used for variety of immunohematological, autoimmune, and immunopathological disorders. In the present communication besides it basic structure, pharmacology and immunoregulation, its use in various hematological disorders is being reviewed. Currently, it is the preferred treatment for conditions such as immune mediated thrombocytopenic purpura, neutropenia, and autoimmune hemolytic anemia.

(PDF emailed within 1 workday: $29.90)

Accession: 046333332

Download citation: RISBibTeXText

PMID: 10773923


Related references

Multiparameter analysis of immunohematological disorders by flow cytometry. Survey and Synthesis of Pathology Research 4(4): 323-340, 1985

Platelet associated immunoglobulins immunoglobulin g immunoglobulin m immunoglobulin a and complement c 3 in immune and nonimmune thrombocytopenic disorders. American Journal of Hematology 23(2): 89-100, 1986

Intravenous immunoglobulin therapy for neuromuscular disorders. Seminars in Neurology 27(4): 340-346, 2007

Intravenous immunoglobulin therapy in neuroimmunological disorders. Ideggyogyaszati Szemle 67(7-8): 281-282, 2015

Intravenous immunoglobulin therapy for neurological disorders. New Zealand Medical Journal 122(1305): 41-46, 2010

Intravenous immunoglobulin therapy in dermatologic disorders. Inflammation and Allergy Drug Targets 7(2): 75-84, 2008

Intravenous immunoglobulin (IVIG) for the therapy of autoimmune disorders. Journal of Clinical Immunology 10(2): 81-89, 1990

Tissue Therapy by the Jarosz Technic in Psychiatric Treatment from An Immunohematological Viewpoint. Ceskoslovenska Psychiatrie 60: 354-356, 1964

The role of intravenous immunoglobulin therapy in autoimmune and inflammatory disorders. Neurological Sciences 23 Suppl 1: S1-S8, 2002

Immunoglobulin therapy modulates the severe inflammatory progression of neuromuscular disorders. Neuromuscular Disorders 27: S192-S193, 2017

Intramuscular versus intravenous immunoglobulin replacement therapy and measurement of immunoglobulin levels during immunoglobulin replacement therapy. Journal of Allergy and Clinical Immunology. in Practice 1(6): 705-706, 2015

Immunoglobulin deficiency with increased immunoglobulin M in three siblings: effect of long-term immunoglobulin therapy. European Journal of Pediatrics 148(3): 215-217, 1988

High-dose intravenous immunoglobulin therapy for immune-mediated disorders. Only immunoglobulins?. Annali Italiani di Medicina Interna 17(1): 9-10, 2002

Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders. Annals of PharmacoTherapy 41(5): 812-823, 2007

Parvovirus B19 infection in a hypogammaglobulinemic infant with neurologic disorders and anemia: successful immunoglobulin therapy. Pediatric Infectious Disease Journal 13(11): 1019-1021, 1994